Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis

We report a 69-year-old female patient with advanced lung cancer who developed myocarditis concomitant with myasthenia gravis (MG), also known as “Herzmyasthenie,” after 3 cycles of nivolumab administration. Her initial symptoms were general malaise and double vision. However, her myocarditis deteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukasawa, Yoko, Sasaki, Kazuya, Natsume, Maika, Nakashima, Makoto, Ota, Shuji, Watanabe, Kiyotaka, Takahashi, Yoshihisa, Kondo, Fukuo, Kozuma, Ken, Seki, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649238/
https://www.ncbi.nlm.nih.gov/pubmed/29070994
http://dx.doi.org/10.1159/000479958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649238/
https://www.ncbi.nlm.nih.gov/pubmed/29070994
http://dx.doi.org/10.1159/000479958

Ejemplares similares